SEARCH

SEARCH BY CITATION

References

  • Abbate, R., Marcucci, R., Camacho-Vanegas, O., Pepe, G., Gori, A.M., Capanni, M., Simonetti, I., Prisco, D. & Gensini, G.F. (1998) Role of platelet glycoprotein PL (A1/A2) polymorphism in restenosis after percutaneous transluminal coronary angioplasty. American Journal of Cardiology, 82, 524525.
  • Antiplatelet Trialists' Collaboration (1994) Collaborative overview of randomised trials of antiplatelet therapy – I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. British Medical Journal, 308, 81106.
  • Bray, P.F. (1999) Integrin polymorphisms as risk factors for thrombosis. Thrombosis and Haemostasis, 82, 337344.
  • Carter, A.M., Ossei-Gerning, N., Wilson, I.J. & Grant, P.J. (1997) Association of the platelet Pl (A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease. Circulation, 96, 14241431.
  • Carter, A.M., Catto, A.J., Bamford, J.M. & Grant, P.J. (1998) Platelet GP IIIa PlA and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke. Arteriosclerosis, Thrombosis and Vascular Biology, 18, 11241131.
  • Cavanagh, G., Dunn, A.N., Chapman, C.E. & Metcalfe, P. (1997) HPA genotyping by PCR sequence-specific priming (PCR-SSP): a streamlined method for rapid routine investigations. Transfusion Medicine, 7, 4145.
  • Cooke, G.E., Bray, P.F., Hamlington, J.D., Pham, D.M. & Goldschmidt-Clermont, P.J. (1998) PlA2 polymorphism and efficacy of aspirin. Lancet, 351, 1253.
  • Corral, J., Lozano, M.L., Gonzalez-Conejero, R., Martinéz, C., Iniesta, J.A., Rivera, J. & Vicente, V. (2000) A common polymorphism flanking the ATG initiator codon of GP1ba does not affect expression and is not a major risk factor for arterial thrombosis. Thrombosis and Haemostasis, 83, 2328.
  • Couch, J.R. & Hassanein, R.S. (1976) Platelet aggregation, stroke, and transient ischemic attack in middle- aged and elderly patients. Neurology, 26, 888895.
  • Del Zoppo, G.J. (1998) The role of platelets in ischemic stroke. Neurology, 51, S9S14.
  • Di Castelnuovo, A., Donati, M.B. & Iacoviello, L. (1999) Platelet glycoprotein receptor IIIa polymorphism PlA1/A2 and vascular risk: a meta-analysis. Thrombosis and Haemostasis, Supplement 386S.
  • Dougherty, J.H.J., Levy, D.E. & Weksler, B.B. (1977) Platelet activation in acute cerebral ischaemia. Serial measurements of platelet function in cerebrovascular disease. Lancet, 1, 821824.
  • Dougherty, J.H.J., Levy, D.E. & Weksler, B.B. (1979) Experimental cerebral ischemia produces platelet aggregates. Neurology, 29, 14601465.
  • Durante-Mangoni, E., Davies, G.J., Ahmed, N., Ruggiero, G. & Tuddenham, E.G. (1998) Coronary thrombosis and the platelet glycoprotein IIIA gene PLA2 polymorphism. Thrombosis and Haemostasis, 80, 218219.
  • Feng, D., Lindpaintner, K., Larson, M.G., Rao, V.S., O'Donnell, C.J., Lipinska, I., Schmitz, C., Sutherland, P.A., Silbershatz, H., D'Agostino, R.B., Muller, J.E., Myers, R.H., Levy, D. & Tofler, G.H. (1999) Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. Arteriosclerosis, Thrombosis and Vascular Biology, 19, 11421147.
  • Garcia-Ribes, M., Gonzalez-Lamuno, D., Hernandez-Estefania, R., Colman, T., Pocovi, M., Delgado-Rodriguez, M., Garcia-Fuentes, M. & Revuelta, J.M. (1998) Polymorphism of the platelet glycoprotein IIIa gene in patients with coronary stenosis. Thrombosis and Haemostasis, 79, 11261129.
  • Gardemann, A., Humme, J., Stricker, J., Nguyen, Q.D., Katz, N., Philipp, M., Tillmanns, H., Hehrlein, F.W., Rau, M. & Haberbosch, W. (1998) Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients. Thrombosis and Haemostasis, 80, 214217.
  • Gonzalez-Conejero, R., Lozano, M.L., Rivera, J., Corral, J., Iniesta, J.A., Moraleda, J.M. & Vicente, V. (1998) Polymorphisms of platelet membrane glycoprotein Ib associated with arterial thrombotic disease. Blood, 92, 27712776.
  • Goodall, A.H., Curzen, N., Panesar, M., Hurd, C., Knight, C.J., Ouwehand, W.H. & Fox, K.M. (1999) Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease. European Heart Journal, 20, 742747.DOI: 10.1053/euhj.1998.1203
  • Herrmann, S.M., Poirier, O., Marques-Vidal, P., Evans, A., Arveiler, D., Luc, G., Emmerich, J. & Cambien, F. (1997) The Leu33/Pro polymorphism (PlA1/PlA2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM Study. Etude Cas-Temoins de l'Infarctus du Myocarde. Thrombosis and Haemostasis, 77, 11791181.
  • Hoogendijk, E.M., Jenkins, C.S., Van Wijk, E.M., Vos, J. & Ten Cate, J.W. (1979) Spontaneous platelet aggregation in cerebrovascular disease II. Further characterisation of the platelet defect. Thrombosis and Haemostasis, 41, 512522.
  • Jin, Y., Dietz, H.C., Nurden, A. & Bray, P.F. (1993) Single-strand conformation polymorphism analysis is a rapid and effective method for the identification of mutations and polymorphisms in the gene for glycoprotein IIIa. Blood, 82, 22812288.
  • Kastrati, A., Schomig, A., Seyfarth, M., Koch, W., Elezi, S., Bottiger, C., Mehilli, J., Schomig, K. & Von Beckerath, N. (1999) PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement. Circulation, 99, 10051010.
  • Keavney, B., Mckenzie, C., Parish, S., Palmer, A., Clark, S., Youngman, L., Delépine, M., Lathrop, M., Peto, R. & Collins, R. for the International Studies of Infarct Survival (ISIS) collaborators (2000) Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. Lancet, 355, 434442.DOI: 10.1016/s0140-6736(99)07192-5
  • Konstantopoulos, K., Grotta, J.C., Sills, C., Wu, K.K. & Hellums, J.D. (1995) Shear-induced platelet aggregation in normal subjects and stroke patients. Thrombosis and Haemostasis, 74, 13291334.
  • Lasne, D., Krenn, M., Pingault, V., Arnaud, E., Fiessinger, J.N., Aiach, M. & Rendu, F. (1997) Interdonor variability of platelet response to thrombin receptor activation: influence of PlA2 polymorphism. British Journal of Haematology, 99, 801807.
  • Laule, M., Cascorbi, I., Stangl, V., Bielecke, C., Wernecke, K.D., Mrozikiewicz, P.M., Felix, S.B., Roots, I., Baumann, G. & Stangl, K. (1999) A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: a case-controlled study. Lancet, 353, 708712.DOI: 10.1016/s0140-6736(98)07257-2
  • Marian, A.J., Brugada, R. & Kleiman, N.S. (1996) Platelet glycoprotein IIIa PlA polymorphism and myocardial infarction. New England Journal of Medicine, 335, 10711072.
  • Meiklejohn, D.J., Urbaniak, S.J. & Greaves, M. (1999) Platelet glycoprotein IIIa polymorphism HPA 1b (PlA2): no association with platelet fibrinogen binding. British Journal of Haematology, 105, 664666.
  • Michelson, A.D. (1996) Flow cytometry: a clinical test of platelet function. Blood, 87, 49254936.
  • Michelson, A.D., Furman, M.I., Goldschmidt-Clermont, P., Mascelli, M.A., Hendrix, C., Coleman, L., Hamlington, J., Barnard, M.R., Kickler, T., Christie, D.J., Kundu, S. & Bray, P.F. (2000) Platelet GP IIIa Pl (A) polymorphisms display different sensitivities to agonists. Circulation, 101, 10131018.
  • Mikkelsson, J., Perola, M., Laippala, P., Savolainen, V., Pajarinen, J., Lalu, K., Penttila, A. & Karhunen, P.J. (1999) Glycoprotein IIIa Pl (A) polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly. Arteriosclerosis, Thrombosis and Vascular Biology, 19, 25732578.
  • Murata, M., Matsubara, Y., Kawano, K., Zama, T., Aoki, N., Yoshino, H., Watanabe, K., Ishikawa, K. & Ikeda, Y. (1997) Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation. Circulation, 96, 32813286.
  • Newman, P.J., Derbes, R.S. & Aster, R.H. (1989) The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. Journal of Clinical Investigation, 83, 17781781.
  • Nurden, A.T. (1995) Polymorphisms of human platelet membrane glycoproteins: structure and clinical significance. Thrombosis and Haemostasis, 74, 345351.
  • Nurden, A.T. (1997) Platelet glycoprotein IIIa polymorphism and coronary thrombosis. Lancet, 350, 11891191.
  • Osborn, S.V., Hampton, K.K., Smillie, D., Channer, K.S. & Daly, M.E. (1996) Platelet glycoprotein IIIa gene polymorphism and myocardial infarction. Lancet, 348, 13091310.
  • Ridker, P.M. & Stampfer, M.J. (1999) Assessment of genetic markers for coronary thrombosis: promise and precaution. Lancet, 353, 687688.DOI: 10.1016/s0140-6736(99)00067-7
  • Ridker, P.M., Hennekens, C.H., Schmitz, C., Stampfer, M.J. & Lindpaintner, K. (1997) PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet, 349, 385388.
  • Robertson, R.M., Robertson, D., Friesinger, G.C., Timmons, S. & Hawiger, J. (1980) Platelet aggregates in peripheral and coronary-sinus blood in patients with spontaneous coronary-artery spasm. Lancet, 2, 829831.
  • Samani, N.J. & Lodwick, D. (1997) Glycoprotein IIIa polymorphism and risk of myocardial infarction. Cardiovascular Research, 33, 693697.DOI: 10.1016/s0008-6363(96)00222-2
  • Shah, A.B., Beamer, N. & Coull, B.M. (1985) Enhanced in vivo platelet activation in subtypes of ischemic stroke. Stroke, 16, 643647.
  • Sonoda, A., Murata, M., Ito, D., Tanahashi, N., Ohta, A., Tada, Y., Takeshita, E., Yoshida, T., Saito, I., Yamamoto, M., Ikeda, Y., Fukuuchi, Y. & Watanabe, K. (2000) Association between platelet glycoprotein Iba genotype and ischemic cerebrovascular disease. Stroke, 31, 493497.
  • Trip, M.D., Cats, V.M., Van Capelle, F.J. & Vreeken, J. (1990) Platelet hyperreactivity and prognosis in survivors of myocardial infarction. New England Journal of Medicine, 322, 15491554.
  • Van Kooten, F., Ciabattoni, G., Patrono, C., Dippel, D.W. & Koudstaal, P.J. (1997) Platelet activation and lipid peroxidation in patients with acute ischemic stroke. Stroke, 28, 15571563.
  • Van Kooten, F., Ciabattoni, G., Koudstaal, P.J., Dippel, D.W. & Patrono, C. (1999) Increased platelet activation in the chronic phase after cerebral ischemia and intracerebral hemorrhage. Stroke, 30, 546549.
  • Wagner, K.R., Giles, W.H., Johnson, C.J., Ou, C.Y., Bray, P.F., Goldschmidt, C.P.J., Croft, J.B., Brown, V.K., Stern, B.J., Feeser, B.R., Buchholz, D.W., Earley, C.J., Macko, R.F., McCarter, R.J., Sloan, M.A., Stolley, P.D., Wityk, R.J., Wozniak, M.A., Price, T.R. & Kittner, S.J. (1998) Platelet glycoprotein receptor IIIa polymorphism P1A2 and ischemic stroke risk: the Stroke Prevention in Young Women Study. Stroke, 29, 581585.
  • Walter, D.H., Schachinger, V., Elsner, M., Dimmeler, S. & Zeiher, A.M. (1997) Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis. Lancet, 350, 12171219.DOI: 10.1016/s0140-6736(97)05399-3
  • Warkentin, T.E., Powling, M.J. & Hardisty, R.M. (1990) Measurement of fibrinogen binding to platelets in whole blood by flow cytometry: a micromethod for the detection of platelet activation. British Journal of Haematology, 76, 387394.
  • Weiss, E.J., Bray, P.F., Tayback, M., Schulman, S.P., Kickler, T.S., Becker, L.C., Weiss, J.L., Gerstenblith, G. & Goldschmidt-Clermont, P.J. (1996) A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. New England Journal of Medicine, 334, 10901094.
  • Zotz, R.B., Winkelmann, B.R., Nauck, M., Giers, G., Maruhn-Debowski, B., Marz, W. & Scharf, R.E. (1998) Polymorphism of platelet membrane glycoprotein IIIa: human platelet antigen 1b (HPA-1b/PlA2) is an inherited risk factor for premature myocardial infarction in coronary artery disease. Thrombosis and Haemostasis, 79, 731735.